| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/16/2011 | CN101977655A Indazole derivatives |
| 02/16/2011 | CN101977606A Methods for treating disorders using nmda nr2b-subtype selective antagonist |
| 02/16/2011 | CN101973946A Phenazine-1-carboxylic acids derivative and preparation method thereof |
| 02/16/2011 | CN101538245B One-class pyridazinone compounds and preparation method and application thereof |
| 02/16/2011 | CN101238106B Fluoro substituted 2-oxo azepan derivatives |
| 02/16/2011 | CN101200464B Method for preparing sartan drug candesartan treating hypertension |
| 02/16/2011 | CN101023064B Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors |
| 02/16/2011 | CN101012203B 1,2,4-triazol derivatives, method for preparing the same |
| 02/15/2011 | USRE42152 FDA Orange book listed patent for plerixafor |
| 02/15/2011 | US7888515 Method for the production of N,N-carbonyldiazoles |
| 02/15/2011 | US7888504 Glucokinase activators and methods of using same |
| 02/15/2011 | US7888384 Heterocyclic derivatives for modulation of calcium channels |
| 02/15/2011 | US7888383 Organic compounds |
| 02/15/2011 | US7888364 Pyridyl inhibitors of hedgehog signalling |
| 02/15/2011 | US7888363 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-amino/thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 02/15/2011 | US7888361 anticancer; inhibits both BCR-ABL and histone deacetylase activity; N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-(hydroxyamino)-2-oxoethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide |
| 02/15/2011 | US7888360 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase |
| 02/15/2011 | US7888357 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death |
| 02/15/2011 | US7888354 Phenylpyrazole derivatives |
| 02/15/2011 | US7888348 7-membered ring compound and method of production and pharmaceutical application thereof |
| 02/15/2011 | US7888287 6-Amino-5-chloro-2-(4-chloro-2,6-difluoro-3-methoxy-phenyl)pyrimidine-4-carboxylic Acid Methyl Ester; preemergence herbicides; applying to the soil in rice fields; broad spectrum of weed control against woody plants, grasses and sedges as well as broadleafs |
| 02/15/2011 | CA2558272C Pyridone derivative |
| 02/15/2011 | CA2449234C Quinazoline derivatives which promote the release of parathyroid hormone |
| 02/15/2011 | CA2446864C Inhibitors of src and other protein kinases |
| 02/10/2011 | WO2011017299A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE |
| 02/10/2011 | WO2011017296A1 4, 5, 6-trisubstituted pyrimidine derivatives as factor ixa inhibitors |
| 02/10/2011 | WO2011016559A1 Heterocyclic compound and use thereof |
| 02/10/2011 | WO2011016528A1 Aminopyrazole derivative |
| 02/10/2011 | WO2011016472A1 Pyridine and pyrimidine derivatives having ttk-inhibiting activity |
| 02/10/2011 | WO2011015728A1 Novel dihydroindolone derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 02/10/2011 | WO2011015658A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | WO2011015657A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | WO2011015629A1 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors |
| 02/10/2011 | WO2011015526A1 Method for stereoselective synthesis of bicyclic heterocyclic compounds |
| 02/10/2011 | US20110034703 Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation |
| 02/10/2011 | US20110034701 One pot process for the preparation of candesartan |
| 02/10/2011 | US20110034689 N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as ErbB Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases |
| 02/10/2011 | US20110034492 N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives |
| 02/10/2011 | US20110034484 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 02/10/2011 | US20110034483 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease |
| 02/10/2011 | US20110034474 Pyridazinone derivatives |
| 02/10/2011 | US20110034470 Inhibitors of JNK |
| 02/10/2011 | US20110034461 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments |
| 02/10/2011 | US20110034459 6,7-dialkoxy quinazoline derivatives and methods of treating drug resistant and other tumors |
| 02/10/2011 | US20110034449 N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase |
| 02/10/2011 | US20110034440 Homocysteine synthase inhibitor |
| 02/10/2011 | US20110034435 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers |
| 02/10/2011 | US20110034434 Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase |
| 02/10/2011 | US20110034433 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use |
| 02/10/2011 | US20110034432 Benzamide derivatives and their use as glucokinase activating agents |
| 02/10/2011 | US20110033911 Episomal fusion gene |
| 02/10/2011 | US20110033393 Hydrazone Compounds and Their Use |
| 02/10/2011 | CA2770195A1 Aminopyrazole derivative |
| 02/10/2011 | CA2768638A1 Bis-benzimidazole derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | CA2768637A1 Phenyl ethynyl derivatives as hepatitis c virus inhibitors |
| 02/10/2011 | CA2767963A1 Stereoselective synthesis of bicyclic heterocycles |
| 02/09/2011 | EP2281822A1 New dihydroindolone derivatives, method of preparing same and pharmaceutical compositions containing them |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281817A1 Substituted carbinol compound having cyclic linker |
| 02/09/2011 | EP2281815A1 4-(Acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1H-indole-1-acetic acid ethyl ester intermediate compound |
| 02/09/2011 | EP2281810A1 Amide compounds, preparation methods and uses thereof |
| 02/09/2011 | EP2281563A1 2,4-Pyrimidinediamine compounds and their uses |
| 02/09/2011 | EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy |
| 02/09/2011 | EP2280962A1 Pyridazinone derivatives |
| 02/09/2011 | EP2280961A1 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 02/09/2011 | EP2280960A1 Novel polymorphic forms of sunitinib base |
| 02/09/2011 | EP2280953A1 New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 02/09/2011 | EP2280948A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers. |
| 02/09/2011 | EP2280943A1 New substituted spiroýcycloalkyl-1,3'-indol¨-2'(1'h)-one derivatives and their use as p38 mitogen-activated kinase inhibitors. |
| 02/09/2011 | EP1831184B1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 02/09/2011 | EP1689715B1 Tubulin inhibitors |
| 02/09/2011 | EP1685100B1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 02/09/2011 | CN101970427A Method for treating pain syndrome and other disorders |
| 02/09/2011 | CN101970426A Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer |
| 02/09/2011 | CN101970423A Fungicide hydroximoyl-tetrazole derivatives |
| 02/09/2011 | CN101970419A Substituted triazinylmethyl sulfonamides |
| 02/09/2011 | CN101970418A Novel compounds, use and preparation thereof |
| 02/09/2011 | CN101970417A Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
| 02/09/2011 | CN101970409A Uv-filter compounds |
| 02/09/2011 | CN101970406A Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 02/09/2011 | CN101970405A Indoles and their therapeutic use |
| 02/09/2011 | CN101970404A Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101108846B 4- fragrant amido quinazoline derivatives and method of manufacturing the same and application in pharmacy thereof |
| 02/08/2011 | US7884214 Condensing 4-Methyl-2-n-propyl-1H-benzimidazole-6-carboxylic acid with N-Methyl-O-phenylenediamine dihydrochloride to yields 4-methyl-6 (1-methyl benzimidazol-2-yl)-2-n-propyl 1H-benzimidazole, treating intermediate with 4'-(bromomethyl)-2-biphenyl-2-carboxylate in presence of a base, salt formation |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7884120 microbiocides such as 2-(2-methyl-1H-indol-3-yl)-3a,11b-dihydro-1H-phenanthro[9,10-d]imidazole; bactericides; fungicides |
| 02/08/2011 | US7884107 Substituted piperidines that increase P53 activity and the uses thereof |
| 02/08/2011 | US7884098 Anthranilamide inhibitors of aurora kinase |
| 02/08/2011 | CA2603784C 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 02/08/2011 | CA2602781C 1h-pyrazole 4-carboxylamides, their preparation and their use as 11beta-hydroxysteroid dehydrogenase |
| 02/08/2011 | CA2586179C Sulfonyl benzimidazole derivatives |
| 02/08/2011 | CA2479906C Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 02/08/2011 | CA2478068C Dihydropyrazole compounds useful for treating or preventing cancer |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2355717C 1,2-annelated quinoline derivatives |
| 02/03/2011 | WO2011014535A1 COMPOUNDS FOR THE REDUCTION OF β-AMYLOID PRODUCTION |
| 02/03/2011 | WO2011014039A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/03/2011 | WO2011013992A2 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |